• 1. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 4. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 5. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Comprehensive Guide to N-Boc-L-homoserine Methyl Ester (CAS No. 120042-11-7): Properties, Applications, and Industry Insights

N-Boc-L-homoserine Methyl Ester (CAS 120042-11-7) is a protected derivative of the non-proteinogenic amino acid L-homoserine, widely utilized in peptide synthesis and pharmaceutical research. This Boc-protected ester offers exceptional stability under acidic conditions, making it a cornerstone in modern organic chemistry workflows. With the rising demand for peptide-based therapeutics and bioconjugation technologies, this compound has garnered significant attention from researchers exploring drug discovery and biomaterial engineering.

The molecular structure of N-Boc-L-homoserine Methyl Ester features two critical functional groups: a tert-butoxycarbonyl (Boc) protecting group at the amine position and a methyl ester at the carboxyl terminus. This dual protection strategy enables selective deprotection during multi-step syntheses, addressing common challenges in solid-phase peptide synthesis (SPPS). Recent studies highlight its role in developing targeted drug delivery systems, particularly in antibody-drug conjugates (ADCs) where controlled release mechanisms are paramount.

Analytical data for CAS 120042-11-7 reveals optimal purity thresholds (>98% by HPLC) for critical applications. The compound's compatibility with green chemistry principles aligns with industry shifts toward sustainable manufacturing. Researchers frequently search for "Boc-homoserine derivative solubility" and "methyl ester deprotection conditions," reflecting practical concerns in laboratory handling. Advanced techniques like microwave-assisted synthesis have demonstrated 40% faster coupling efficiency when incorporating this building block.

In biotechnology applications, the compound serves as a precursor for unnatural amino acid incorporation via genetic code expansion. Its molecular weight (245.29 g/mol) and lipophilicity (LogP ~1.2) make it particularly valuable for designing cell-penetrating peptides. The growing peptidomimetics market, projected to reach $6.8 billion by 2028, underscores the commercial relevance of such intermediates. Stability studies indicate excellent shelf life (>24 months at -20°C) when stored under anhydrous conditions.

Quality control protocols for 120042-11-7 typically involve chiral HPLC analysis to ensure enantiomeric purity, crucial for maintaining biological activity in final products. The compound's crystalline form (melting point 82-85°C) facilitates precise weighing and handling. Recent patent filings reveal innovative uses in bioorthogonal chemistry, particularly for click chemistry modifications in live cell imaging. These developments respond to the increasing demand for "multifunctional peptide linkers" in diagnostic applications.

From a regulatory perspective, N-Boc-L-homoserine Methyl Ester complies with REACH and FDA guidelines for research compounds. Its non-hygroscopic nature reduces handling complications compared to unprotected amino acid derivatives. The scientific community actively investigates its potential in enzyme inhibitor design, with particular interest in protease-targeting therapeutics. Computational chemistry studies suggest favorable binding energies when incorporated into protein-protein interaction modulators.

Industrial-scale production employs continuous flow chemistry methods to enhance yield and reduce solvent waste. The compound's MSDS profile indicates standard organic compound precautions, with no special hazards beyond typical laboratory chemicals. Emerging applications in material science include its use as a monomer for biodegradable polymer synthesis, capitalizing on the ester group's reactivity. These innovations align with global trends toward sustainable biomaterials in medical devices.

For analytical chemists, 120042-11-7 presents distinct NMR signatures: a characteristic Boc tert-butyl singlet at 1.44 ppm and methyl ester resonance at 3.72 ppm in DMSO-d6. These markers facilitate rapid quality verification. The compound's scalable synthesis route from L-methionine makes it cost-effective for industrial applications. Recent breakthroughs in automated peptide synthesizers have increased demand for such protected amino acid derivatives with reliable coupling efficiency.

The future outlook for N-Boc-L-homoserine Methyl Ester remains robust, driven by expansion in personalized medicine and therapeutic peptides. Its structural versatility supports development of multi-arm linker systems for complex biomolecule assembly. As research into peptide vaccines accelerates, this intermediate's role in creating immunogenic epitopes continues to grow. Proper storage recommendations (desiccated, inert atmosphere) ensure consistent performance across these cutting-edge applications.

• 40856-59-5((S)-(-)-α-(N-t-BOC-Amino)-γ-butyrolactone)
• 55747-84-7(L-Aspartic acid, N-[(1,1-dimethylethoxy)carbonyl]-, dimethyl ester)
• 77004-75-2(N-Boc-D-aspartic Acid 1-tert-Butyl Ester)
• 67198-86-1(Boc-D-Homoserine lactone)
• 147325-09-5((S)-N-Boc-L-homoserine Ethyl Ester)
• 34582-32-6((S)-4-(tert-Butoxy)-3-((tert-butoxycarbonyl)amino)-4-oxobutanoic acid)
• 258351-86-9(D-Homoserine,N-[(1,1-dimethylethoxy)carbonyl]-, methyl ester)
• 428440-11-3(D-Aspartic acid,N-[(1,1-dimethylethoxy)carbonyl]-, 1,4-diethyl ester)
• 132957-40-5(tert-butyl (tetrahydro-2-oxo-3-furanyl)carbamate)
• 86938-08-1(L-Aspartic acid, N-[(1,1-dimethylethoxy)carbonyl]-, 1-ethyl ester)